ResearcherZhuzhou Central HospitalNo recent work listed

Zemin Zhu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5101135607. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macrophage M1 polarization and regulate gut m… Co-author DOI 10.1186/s12885-023-11557-z ↗
Molecular Analysis of Prognosis and Immune Pathways of Pancreatic Cancer Based on TNF Family Members. Co-author DOI 10.1155/2021/2676996 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhijian Zhao · 2 shared papers, 2021–2023 · strength 0.38
- Paper Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macro… DOI 10.1186/s12885-023-11557-z ↗
- Paper Molecular Analysis of Prognosis and Immune Pathways of Pancreatic Cancer Based on TNF Family Members. DOI 10.1155/2021/2676996 ↗
Caixi Tang · 2 shared papers, 2021–2023 · strength 0.38
- Paper Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macro… DOI 10.1186/s12885-023-11557-z ↗
- Paper Molecular Analysis of Prognosis and Immune Pathways of Pancreatic Cancer Based on TNF Family Members. DOI 10.1155/2021/2676996 ↗
Ming Li · 1 shared paper, 2023 · strength 0.19
- Paper Lactobacillus casei combined with Lactobacillus reuteri alleviate pancreatic cancer by inhibiting TLR4 to promote macro… DOI 10.1186/s12885-023-11557-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.